Detalles de la búsqueda
1.
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Lancet
; 401(10373): 269-280, 2023 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36709073
2.
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.
Blood
; 140(14): 1635-1649, 2022 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35344580
3.
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis.
Am J Hematol
; 99(4): 755-758, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291566
4.
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies.
Value Health
; 27(5): 607-613, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38311180
5.
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study.
J Med Virol
; 95(7): e28933, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37403897
6.
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.
Ann Hematol
; 102(2): 447-456, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36422672
7.
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
Cancer
; 128(13): 2441-2448, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417564
8.
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.
Br J Haematol
; 199(4): 529-538, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089912
9.
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.
Blood
; 135(5): 381-386, 2020 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31869407
10.
The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study.
Eur J Haematol
; 106(3): 371-379, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33275803
11.
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.
Biol Blood Marrow Transplant
; 26(12): 2237-2244, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32717433
12.
Second cancers in MPN: Survival analysis from an international study.
Am J Hematol
; 95(3): 295-301, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31816122
13.
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.
Eur J Haematol
; 102(1): 79-86, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267597
14.
CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic Syndrome .
Biol Blood Marrow Transplant
; 24(5): 964-972, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29305194
15.
Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors.
Br J Haematol
; 200(6): e58-e61, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36652997
16.
Prognostic risk models for transplant decision-making in myelofibrosis.
Ann Hematol
; 97(5): 813-820, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29396714
17.
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant
; 23(7): 1177-1185, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28396159
18.
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
Haematologica
; 102(1): 103-109, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27686377
19.
Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis.
Eur J Haematol
; 98(4): 407-414, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28009442
20.
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Am J Hematol
; 97(12): E470-E473, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111658